Morgan Stanley, IBD Stock Of The Day, Breaks Out On Blowout Earnings As Key Merger Looms

Morgan Stanley, IBD Stock Of The Day, Breaks Out On Blowout Earnings As Key Merger Looms

Morgan Stanley earnings blew out Q2 estimates as trading revenue soared, lifting the stock into buy range.